Key Highlights of the NDCT Amendment Rules 2026: Transforming India’s Clinical Research Landscape
The clinical research and pharmaceutical sectors in India are undergoing a profound evolution. To streamline drug development, eliminate procedural bottlenecks, and align national standards with global frameworks, the Ministry of Health and Family Welfare (MoHFW) and the Central Drugs Standard Control Organization (CDSCO) introduced the landmark New Drugs and Clinical Trials (NDCT) Amendment...
0 Комментарии 0 Поделились 0 предпросмотр